EnteraSense develops diagnostic medical devices that utilize advanced biosensor technology to detect and monitor specific health conditions in real-time. The company addresses the need for accurate and timely diagnostics, improving patient outcomes and reducing the burden on healthcare systems.
Funding
$4.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Real-time monitoring of specific health conditions often requires invasive procedures or laboratory testing, leading to delays in diagnosis and treatment. Current diagnostic methods may lack the accuracy and speed needed for timely intervention and improved patient outcomes.
Solution
EnteraSense is developing advanced biosensor technology integrated into diagnostic medical devices for real-time detection and monitoring of health conditions. These devices aim to provide accurate and rapid results, enabling clinicians to make informed decisions and initiate timely treatment. By offering a less invasive and faster alternative to traditional diagnostic methods, EnteraSense seeks to improve patient outcomes and reduce the strain on healthcare systems.
Target Audience
The primary target audience includes healthcare providers, hospitals, and diagnostic laboratories seeking improved methods for real-time patient monitoring and disease detection.
Features
- Advanced biosensor technology for real-time detection
- Integration into diagnostic medical devices
- Non-invasive or minimally invasive monitoring capabilities
- Rapid and accurate results for timely intervention